CS(=O)(=O)O.Cc1cc(-c2c(F)cc3c4nn([C@H]5CC[C@@H](N(C)C)CC5)c(=O)c-4cn(C4CC4)c3c2F)cc(C)n1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?